tirzepatide rate of weight loss as Compared with Semaglutide for the Treatment Obesity Tirzepatide outperformed semaglutide weight-loss drug
Description
doi: 10.1172/JCI10842 [DOI] [PMC free article] [PubMed] [Google Scholar] 114
administered semaglutide at a dose of 30 nmol/kg daily via subcutaneous injection to obese mice for 22 days pre-pregnancy and observed a reduction in body weight and improvement of insulin sensitivity in the animals during the pre-pregnancy semaglutide treatment, which was associated with an improvement in fertility after the drug was stopped [36]
Serious risks include birth defects during pregnancy
The procedure of mounjaro medications is carried out in various steps, which are as follows
